Randomized Controlled Clinical Trial to Access Efficacy and Safety of Miltefosine in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania (Viannia) guyanensis in Manaus, Brazil

Miltefosine has been used in the treatment of several new world cutaneous leishmaniasis (CL) species with variable efficacy. Our study is the first evidence on its clinical efficacy in Leishmania (Viannia) guyanensis. In this phase II/III randomized clinical trial, 90 CL patients were randomly alloc...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Chrusciak-Talhari, Anette, Dietze, Reynaldo, Chrusciak Talhari, Carolina, da Silva, Roberto Moreira, Gadelha Yamashita, Ellen Priscila, de Oliveira Penna, Gerson, Lima Machado, Paulo Roberto, Talhari, Sinésio
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: The American Society of Tropical Medicine and Hygiene 2011
Onderwerpen:
Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3029178/
https://ncbi.nlm.nih.gov/pubmed/21292895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.2011.10-0155
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items